ATE308564T1 - Zusammensetzungen und verfahren des synaptischen aktivierungsproteins - Google Patents
Zusammensetzungen und verfahren des synaptischen aktivierungsproteinsInfo
- Publication number
- ATE308564T1 ATE308564T1 AT98909181T AT98909181T ATE308564T1 AT E308564 T1 ATE308564 T1 AT E308564T1 AT 98909181 T AT98909181 T AT 98909181T AT 98909181 T AT98909181 T AT 98909181T AT E308564 T1 ATE308564 T1 AT E308564T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- sequence
- methods
- synaptic activation
- coding sequences
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 230000004913 activation Effects 0.000 title abstract 2
- 230000000946 synaptic effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000002773 nucleotide Substances 0.000 abstract 3
- 125000003729 nucleotide group Chemical group 0.000 abstract 3
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 abstract 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 239000012636 effector Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 210000001320 hippocampus Anatomy 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000001537 neural effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3655397P | 1997-03-14 | 1997-03-14 | |
| PCT/US1998/004983 WO1998040407A1 (en) | 1997-03-14 | 1998-03-13 | Synaptic activation protein compositions and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE308564T1 true ATE308564T1 (de) | 2005-11-15 |
Family
ID=21889236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98909181T ATE308564T1 (de) | 1997-03-14 | 1998-03-13 | Zusammensetzungen und verfahren des synaptischen aktivierungsproteins |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6294355B1 (de) |
| EP (1) | EP0970119B9 (de) |
| JP (1) | JP4127861B2 (de) |
| AT (1) | ATE308564T1 (de) |
| AU (1) | AU733575B2 (de) |
| CA (1) | CA2287591A1 (de) |
| DE (1) | DE69832156T2 (de) |
| ES (1) | ES2255152T3 (de) |
| WO (1) | WO1998040407A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002525113A (ja) * | 1998-09-25 | 2002-08-13 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 膜関連組織化タンパク質 |
| EP1027890A3 (de) * | 1998-12-16 | 2000-09-06 | Knoll Aktiengesellschaft | Homer ein neues Ziel für die Behandlung von psychiatrischen Krankheiten |
| US6942981B1 (en) | 1999-05-14 | 2005-09-13 | Arbor Vita Corporation | Method of determining interactions with PDZ-domain polypeptides |
| GB0005700D0 (en) * | 2000-03-09 | 2000-05-03 | Glaxo Group Ltd | Therapy |
| AU2003247579A1 (en) * | 2002-06-19 | 2005-02-04 | The Johns Hopkins University School Of Medicine | Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| WO2012058201A2 (en) * | 2010-10-26 | 2012-05-03 | President And Fellows Of Harvard College | Method for determining activators of excitatory synapse formation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5767252A (en) | 1996-04-08 | 1998-06-16 | The Johns Hopkins University School Of Medicine | Neuronal cell growth factor, Narp |
-
1998
- 1998-03-13 DE DE69832156T patent/DE69832156T2/de not_active Expired - Fee Related
- 1998-03-13 US US09/042,428 patent/US6294355B1/en not_active Expired - Lifetime
- 1998-03-13 CA CA002287591A patent/CA2287591A1/en not_active Abandoned
- 1998-03-13 WO PCT/US1998/004983 patent/WO1998040407A1/en not_active Ceased
- 1998-03-13 AU AU67026/98A patent/AU733575B2/en not_active Ceased
- 1998-03-13 EP EP98909181A patent/EP0970119B9/de not_active Expired - Lifetime
- 1998-03-13 ES ES98909181T patent/ES2255152T3/es not_active Expired - Lifetime
- 1998-03-13 AT AT98909181T patent/ATE308564T1/de not_active IP Right Cessation
- 1998-03-13 JP JP53985898A patent/JP4127861B2/ja not_active Expired - Fee Related
-
2001
- 2001-07-20 US US09/910,706 patent/US6780600B2/en not_active Expired - Lifetime
-
2004
- 2004-06-10 US US10/866,256 patent/US7399830B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001517217A (ja) | 2001-10-02 |
| AU733575B2 (en) | 2001-05-17 |
| US6780600B2 (en) | 2004-08-24 |
| JP4127861B2 (ja) | 2008-07-30 |
| US20030027147A1 (en) | 2003-02-06 |
| AU6702698A (en) | 1998-09-29 |
| EP0970119B9 (de) | 2006-06-28 |
| WO1998040407A1 (en) | 1998-09-17 |
| US20040229274A1 (en) | 2004-11-18 |
| DE69832156D1 (de) | 2005-12-08 |
| DE69832156T2 (de) | 2006-08-03 |
| US7399830B2 (en) | 2008-07-15 |
| US6294355B1 (en) | 2001-09-25 |
| EP0970119B1 (de) | 2005-11-02 |
| CA2287591A1 (en) | 1998-09-17 |
| ES2255152T3 (es) | 2006-06-16 |
| EP0970119A1 (de) | 2000-01-12 |
| EP0970119A4 (de) | 2004-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aota et al. | The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. | |
| ZA200803403B (en) | Botulinum neurotoxin a protein receptor and use thereof | |
| CA2395724A1 (en) | NUCLEIC ACIDS, PROTEINS AND ANTIBODIES | |
| Huang et al. | Complete amino acid sequence of human phosphoglycerate kinase. Cyanogen bromide peptides and complete amino acid sequence. | |
| IL191077A0 (en) | An isolated antibody which binds to the n-terminal domain of gamma-heregulin and methods using it | |
| EP1100811A4 (de) | Für einen g-protein gekoppelten rezeptor, der an der empfindungstransduktion beteiligt ist, kodierende nukleinsäuren | |
| BR9507618A (pt) | Frações polipeptidicas solúveis da proteína lag-3 processo de produção composição terapêutica anticorpos anti-idiotipo | |
| PT1007654E (pt) | Biblioteca de expressao de proteina ou peptido in vitro | |
| ATE522610T1 (de) | Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen | |
| SE9704836D0 (sv) | Novel receptor | |
| BR9912545A (pt) | ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial | |
| PT907731E (pt) | Receptores gaba[b] metabotropicos, ligandos especificos dos receptores e suas utilizacoes | |
| ATE483806T1 (de) | Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide | |
| DE69636437D1 (de) | Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung | |
| WO2003104282A8 (en) | Glycoprotein vi - fc fusion protein for treating vascular disorders | |
| DK0948604T3 (da) | Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet | |
| DE69435020D1 (en) | Protein-tyrosin-phosphatase ptp-s31 | |
| ATE323771T1 (de) | Fragment des menschlichen erythropoietinrezeptors und antikörper dagegen | |
| CY1108568T1 (el) | Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α | |
| ATE308564T1 (de) | Zusammensetzungen und verfahren des synaptischen aktivierungsproteins | |
| DE69938240D1 (de) | Neuer g-protein-gekoppelter rezeptor | |
| DE602005019495D1 (de) | Ligand für den Formylpeptidrezeptorähnlichen- 2 (FPRL2) G Protein gekoppelten Rezeptor und dessen Anwendung | |
| IL146450A0 (en) | Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction | |
| WO2002026930A3 (en) | Nucleic acids, proteins, and antibodies | |
| EA200700951A1 (ru) | БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0970119 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |